MBX Capital
PE / VC · New York · United States
Etapas
Región de inversión
Industrias
Perfil
MBX Capital is a venture capital firm founded in 2015, based in Claymont, Delaware. The firm specializes in early-stage investments in healthcare, biotechnology, and "deep health" companies that integrate biology, chemistry, AI/ML, robotics, and clinical medicine. As of June 2024, MBX Capital manages over $100 million in assets and focuses on pre-seed, seed, and Series A funding rounds. The firm targets startups that address public health challenges, including environmental health, healthcare infrastructure, and chronic diseases. MBX Capital typically invests between $100K and $3M, with initial checks ranging from $1 to $2.5 million for at least 5% ownership. They support founders through their Atom Network, which connects them with a wide range of scientific and industry experts. MBX Capital has made 37 investments across more than 30 companies, with a portfolio that includes life sciences, consumer products, and business services.
Contactos (2)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.